ethyl 1-cyclopropyl-9-methyl-4-oxo-8-tributylstannyl-4H-quinolizine-3-carboxylate | 483370-60-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹嗪类
• 英文名称: ethyl 1-cyclopropyl-9-methyl-4-oxo-8-tributylstannyl-4H-quinolizine-3-carboxylate
• 英文别名: ethyl 1-cyclopropyl-9-methyl-4-oxo-8-tributylstannylquinolizine-3-carboxylate
• CAS: 483370-60-1
• 化学式: C₂₈H₄₃NO₃Sn
• 分子量: 560.364
• InChiKey: JVZOGRSRVBRRJQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.72
• 重原子数：
  33
• 可旋转键数：
  14
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl 1-cyclopropyl-9-methyl-4-oxo-8-tributylstannyl-4H-quinolizine-3-carboxylate 、 2-(Boc-氨基)-5-溴吡啶 在 四(三苯基膦)钯 silver(l) oxide 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 1.08h， 生成 ethyl 8-(6-tert-butoxycarbonylaminopyridin-3-yl)-1-cyclopropyl-9-methyl-4-oxo-4H-quinolizine-3-carboxylate
  参考文献：
  名称：

  4-OXOQUINOLIZINE ANTIMICROBIALS HAVING 2-PYRIDONE SKELETON AS PARTIAL STRUCTURE

  摘要：

  公开号：

  EP1437354B1
• 作为产物：
  描述：

  ethyl 8-chloro-1-cyclopropyl-9-methyl-4-oxo-4H-quinolizine-3-carboxylate 、 六正丁基二锡 在 bis-triphenylphosphine-palladium(II) chloride 作用下， 以 甲苯 为溶剂， 反应 3.0h， 生成 ethyl 1-cyclopropyl-9-methyl-4-oxo-8-tributylstannyl-4H-quinolizine-3-carboxylate
  参考文献：
  名称：

  4-OXOQUINOLIZINE ANTIMICROBIALS HAVING 2-PYRIDONE SKELETON AS PARTIAL STRUCTURE

  摘要：

  公开号：

  EP1437354B1

文献信息

• 4-Oxoquinolizine antibacterial agent having 2-pyridone skeleton as partial structure
  申请人：SATO PHARMACEUTICAL CO., LTD.

  公开号：US20040229903A1

  公开（公告）日：2004-11-18

  The present invention provides a 4-oxoquinolizine antibacterial agent having a 2-pyridone skeleton as a partial structure and also having a strong antibacterial effect on gram-positive bacteria, gram-negative bacteria or anaerobic bacteria. The compound having the following formula (I) or a pharmaceutically acceptable salt thereof: 1 wherein: R 1 represents hydrogen atom or a carboxyl-protecting group, R 2 represents hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxyl group or hydroxyl group, R 3 represents phenyl group or an aromatic substituent selected from the group consisting of 5-membered and 6-membered heterocyclic groups and R 3 has a substituent selected from the group consisting of a hydrogen atom, a lower alkyl group, a lower alkoxyl group, a nitro group, a cyano group, an amino group, an acyl group, a carbamoyl group and a ureido group, and R 4 represents a hydrogen atom or a halogen atom.

  本发明提供了一种具有2-吡啶酮骨架作为部分结构并对革兰氏阳性菌、革兰氏阴性菌或厌氧菌具有强烈抗菌作用的4-氧喹啉类抗菌剂。该化合物具有以下式（I）或其药学上可接受的盐：1其中：R1代表氢原子或羧基保护基，R2代表氢原子、卤素原子、较低的烷基、较低的烷氧基或羟基，R3代表苯基或从5-成员和6-成员杂环基组成的芳香基取代基，且R3具有从氢原子、较低的烷基、较低的烷氧基、硝基、氰基、氨基、酰基、氨基甲酰基和尿素基组成的取代基，以及R4代表氢原子或卤素原子。
• 4-oxoquinolizine antibacterial agent having 2-pyridone skeleton as partial structure
  申请人：Salo Pharmaceutical Co., Ltd.

  公开号：US07223773B2

  公开（公告）日：2007-05-29

  The present invention provides a 4-oxoquinolizine antibacterial agent having a 2-pyridone skeleton as a partial structure and also having a strong antibacterial effect on gram-positive bacteria, gram-negative bacteria or anaerobic bacteria. The compound having the following formula (I) or a pharmaceutically acceptable salt thereof: wherein: R1 represents hydrogen atom or a carboxyl-protecting group, R2 represents hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxyl group or hydroxyl group, R3 represents phenyl group or an aromatic substituent selected from the group consisting of 5-membered and 6-membered heterocyclic groups and R3 has a substituent selected from the group consisting of a hydrogen atom, a lower alkyl group, a lower alkoxyl group, a nitro group, a cyano group, an amino group, an acyl group, a carbamoyl group and a ureido group, and R4 represents a hydrogen atom or a halogen atom.

  本发明提供了一种具有2-吡啶酮骨架部分结构并对革兰氏阳性菌、革兰氏阴性菌或厌氧菌具有强烈抗菌作用的4-氧喹啉酮抗菌剂。该化合物具有以下式子(I)或其药学上可接受的盐：其中：R1代表氢原子或羧基保护基，R2代表氢原子、卤素原子、低碳基、低碳氧基或羟基，R3代表苯基或从5元和6元杂环基组成的芳香取代基，R3具有从氢原子、低碳基、低碳氧基、硝基、氰基、氨基、酰基、氨基甲酰基和尿素基组成的取代基，R4代表氢原子或卤素原子。
• 4-OXOQUINOLIZINE ANTIMICROBIALS HAVING 2-PYRIDONE SKELETON AS PARTIAL STRUCTURE
  申请人：Sato Pharmaceutical Co. Ltd.

  公开号：EP1437354B1

  公开（公告）日：2008-08-13